Working with leading academic institutions and companies we have protected lead clinical candidates.

We also have substantial experience in developing and successfully implementing pan-European launch strategies for pharmaceutical products.  This includes conducting comprehensive freedom to operate assessments to identify blocking IP rights followed by disputes before the European Patent Office and UK Courts to revoke those rights, enabling clients to bring their products to market.